Inflammatory bowel disease (IBD) research at Mayo Clinic April 09, 2021 Overview Show transcript Overview Mayo Clinic gastroenterologist William A. Faubion Jr., M.D., discusses how ongoing IBD research and harnessing the power of artificial intelligence (AI) and machine learning (ML) offer tremendous applications in understanding disease patterns, predictive modeling and targeting therapeutic interventions. At Mayo Clinic, we are on the forefront of applying these technologies and developing new treatments to benefit patients with IBD. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleExamining clinical and genetic factors that impact response to anti-TNF agents in patients with IBDArticleResearch establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseases VID-20511062 Medical Professionals Inflammatory bowel disease (IBD) research at Mayo Clinic